Back to search

Switzerland· 51884002

Physiotens 0,3 mg, Filmtabletten

A moxonidine product, registered in Switzerland by Viatris Pharma GmbH and dispensed under Swissmedic category B. The same ATC class is registered in 13 of our 19 countries.

Cat B (Swissmedic)ATC C02AC05

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedPhysiotens 0,3 mg, FilmtablettenATCC02AC05REGISTER NO.51884002PACKS LISTED0CHECKEDJune 26, 2026

Where it is registered

Moxonidine is registered in 13 of 19 countries.

Countries holding a registration under ATC C02AC05 (moxonidine), each read from that country’s own register.

  • This record: Switzerland
  • 8 of them publish a price we can compare per daily dose

Moxonidine · ATC C02AC05

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of moxonidine costs, country by country.

Normalised to the WHO defined daily dose (0.3 mg), the median price runs from $0.19 in France to $0.70 in Switzerland — a ×3.7 gap.

  • Switzerland: $0.70 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Moxonidine · price per daily dose (0.3 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.70
  • IT Italy$0.35
  • FR France$0.19
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Manufacturer
Viatris Pharma GmbH
Country
Switzerland (CH)
ATC code
C02AC05
ATC class
Moxonidine
Defined daily dose
0.3 mg, O
Swissmedic category
B
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cd1561f4-934e-45e2-9cc2-0b0040b5ff86
GET /v1/drugs/cd1561f4-934e-45e2-9cc2-0b0040b5ff86?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}

See everything about moxonidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.